Overview

Cumulative Irritation Test

Status:
Completed
Trial end date:
2007-02-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Pharmaceutical Solutions
Tavaborole